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Sex differences2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is an environmental contaminant that producesmyriad toxicities in
most mammals. In rodents alone, there is a huge divergence in the toxicological response across species, as well
as among different strains within a species. But there are also signiﬁcant differences betweenmales and females
animals of a single strain. These differences are inconsistent across model systems: the severity of toxicity is
greater in female rats than males, while male mice and guinea pigs are more sensitive than females. Because
the speciﬁc events that underlie this difference remain unclear, we characterized the hepatic transcriptional
response of adult male and female C57BL/6 mice to 500 μg/kg TCDD at multiple time-points.
The transcriptional proﬁle diverged signiﬁcantly between the sexes. Female mice demonstrated a large number
of altered transcripts as early as 6 h following treatment, suggesting a large primary response. Conversely, male
animals showed the greatest TCDD-mediated response 144 h following exposure, potentially implicating signif-
icant secondary responses. Nr1i3 was statistically signiﬁcantly induced at all time-points in the sensitive male
animals. This mRNA encodes the constitutive androstane receptor (CAR), a transcription factor involved in the
regulation of xenobiotic metabolism, lipid metabolism, cell cycle and apoptosis. Surprisingly though, changes
at the protein level (aside from the positive control, CYP1A1)weremodest, with only FMO3 showing clear induc-
tion, and no genes with sex-differences. Thus, while male and female mice show transcriptional differences in
their response to TCDD, their association with TCDD-induced toxicities remains unclear.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Introduction
Chlorinated dioxins are a class of chemically-similar compounds pro-
duced as byproducts of industrial processes such as low temperature in-
cineration and electronics recycling (Shen et al., 2009), as well as
historically through the manufacture of herbicides and pesticides
(Schecter et al., 2006). 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is
the most potent dioxin, eliciting a range of toxic and biochemical
responses including chloracne, thymic atrophy, hepatotoxicity, wasting
syndrome and cancer (Pohjanvirta and Tuomisto, 1994). In addition, ges-
tational exposure results in various reproductive abnormalities in mice,
such as reduced sperm count and decreased uterine weight (Theobald
and Peterson, 1997), and rats, including abnormal lung morphologyent; ARI, Adjusted Rand Index;
us; H/W, Han/Wistar rats; L-E,
in.
ncer Research, Suite 510, 661
.
. This is an open access article under(Kransler et al., 2009) and an altered transcriptome of the developing
sex organs (Magre et al., 2012). After a single exposure, TCDD accumu-
lates within the liver and adipose tissues of rats and mice (Pohjanvirta
et al., 1990; Diliberto et al., 1995) and causes dose-dependent toxicities,
such as increased liver weight (Boverhof et al., 2005).
Essentially all of the TCDD-associated toxic effects are mediated
through its interaction with the aryl hydrocarbon receptor (AHR).
Activation of this receptor results in nuclear translocation and
heterodimerization with the AHR nuclear translocator (ARNT). This
complex then recognizes and binds to aryl hydrocarbon response
elements (AHREs) and regulates transcription. Evidence that TCDD
toxicities occur via the AHR come from studies examining the signiﬁ-
cantly diminished toxic outcomes observed in both AHR knockout mice
(Fernandez-Salguero et al., 1996; Mimura et al., 1997) and mice with
mutant AHREs (Bunger et al., 2003). In addition, studies of hepatocyte-
speciﬁc ARNT-null mice observed reduced hepatotoxicity following
exposure to TCDD (Nukaya et al., 2010).
There is a wide disparity in the toxic effects of TCDD among different
animal models. For example acute lethality, as measured by the LD50, is
highly variable for different species: ~1 and 5100 μg/kg for guinea pigsthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
Table 1
Candidate genes summary.
Table shows if the candidate genewas signiﬁcantly altered in a given comparison (q b 0.01).
Candidate genes were identiﬁed as those targets signiﬁcantly differentially expressed be-
tween TCDD-treated and corn-oil control groups at 3 or more time-points in either male
or female mice. A total of 20 candidate genes were identiﬁed.
Comparison Male (T–C) Female(T–C) Male (C)–Female(C)
Time-point 6 24 72 144 6 24 72 144 6 24 72 144
Smcp + + + − + − − − − − − −
Dclk3 + + + + + − − − − − − −
Fmo3 + + + + − − − + + + + +
Fmo2 + + + + + − − − − + − +
Nup155 + + + + + − − − − − − −
Slc18a2 + − + + + − − − − − − −
Atoh8 + − + + + − − − − − − −
Nr1i3 + − + + + − − − − − + −
Gadd45b − + + + − − − + − − − −
Sec61a2 + − + + + − − − − − − −
Serpina6 + − + + − − − − − − − −
Prhoxnb + − + + + − − − − − − −
Ugt1a9 − + + + − − − + − − − −
Tmem62 + − + + − − − + − − − −
Ces1b − + + + − − − − − − − −
Tlr5 − + + + + − − − − − − −
Aig1 − + + + + − − − − − − −
Ces4a − + + + − − − − + − − −
Klhdc7a − + + + − − − + − − − −
Gpd2 − + + + − − − − − − − −
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Fig. 1. Experimental design. Outline of the experimental design: 65 adult male and female
C57BL/6micewere treatedwith either 500 μg/kgTCDDor cornoil and euthanized 6, 24, 72
or 144 h post-treatment. Liver tissue was harvested and RNA isolated. Samples were hy-
bridized onto Affymetrix MouseGene1.1ST arrays. Data were pre-processed using RMA
normalization. Quality control identiﬁed outliers which were removed; data were then
re-normalized. Probe-level ﬁltering was performed based on intensity levels of chromo-
some Y probes in female animals. Data underwent statistical analyses, results were visual-
ized and validation of potential toxicity-related targets performed by western blot.
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Similarly, toxicity varies among different strains within a species: the
LD50 for Long-Evans (L-E) rats is ~10 μg/kg while Han/Wistar (H/W)
rats can tolerate upwards of 9600 μg/kg with minimal effects
(Pohjanvirta et al., 1999). In many of these cases, the difference in sen-
sitivities is a result of variations within the Ahr gene. A point mutation
leads to splicing-generated alteration of the transactivation domain of
the H/W rat AHR rendering it refractory to TCDD toxicities while the
wild-type L-E rat is one of the most sensitive responders (Pohjanvirta
et al., 1998). These differing sensitivities have allowed researchers to
compare and contrast the transcriptomic responses to TCDD across
species (Boverhof et al., 2006; Boutros et al., 2008; Dere et al., 2011;
Forgacs et al., 2013; Nault et al., 2013) and between strains/lines within
a species (Franc et al., 2008; Pohjanvirta, 2009; Yao et al., 2012).
But differences in sensitivities have also been identiﬁedwithin a sin-
gle strain, between male and female animals (Pohjanvirta et al., 1993;
Enan et al., 1996; Silkworth et al., 2008). In L-E rats, female animals
are more sensitive to the acute lethality of TCDD (LD50 = 9.8 μg/kg)
while males are more resistant (LD50 = 17.7 μg/kg) (Pohjanvirta et al.,
1993). Alternatively in guinea pigs, male animals are more susceptible
than females (Enan et al., 1996). Recently, it was discovered that, unlike
in rats and similar to guinea pigs, female mice are less sensitive than
males and develop fewer toxicities (Pohjanvirta, 2009). The pattern in
mice did not extend to all other sub-strains examined (Pohjanvirta,
2009), however was later conﬁrmed through extensive analyses of the
physiological effects of TCDD on these mice (Pohjanvirta et al., 2012).
Furthermore, this differential response is caused, at least in part, by
the sex hormones; ovariectomized mice proved more sensitive while
castrated mice are more resistant to TCDD-induced lethality than intact
mice (Pohjanvirta et al., 2012). Here we attempt to identify the speciﬁc
TCDD-mediated transcriptional events in the liver responsible for the
divergent sensitivity phenotypes between male and female mice.Results
Experimental design
We have characterized the speciﬁc hepatic transcriptional modiﬁca-
tions associated with the differential TCDD-toxicity phenotypesobserved in male and female C57BL/6 mice. Adult male and female
mice were treated with either TCDD in corn oil vehicle or corn oil
alone, and transcriptional proﬁling was performed on hepatic tissue
collected 6, 24, 72 or 144 h after treatment. Animals were followed
along this time-course to evaluate the progressive transcriptomic
changes. In thiswaywe sought to identify both the primary and second-
ary TCDD:AHR-mediated responses. The experimental approach is
outlined in Fig. 1 and sample information, including identiﬁcation of
outliers, is in Supplementary Table 1.
Overview of transcriptomic responses
We ﬁrst assessed the overall transcriptomic responses of the liver by
examining those transcripts with highest variance across our samples
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partitioning of samples, based on these transcripts alone (ARISex =
0.06; ARITreatment = 0.06; ARITime = 0.01). Following linear modeling
(see Methods), a p-value sensitivity analysis was conducted to deter-
mine the optimal threshold for downstream analyses (Fig. 2B, Supple-
mentary Fig. 5). Venn diagrams were used to visualize overlap of
signiﬁcantly altered transcripts across the time-course. Comparison of
male and female vehicle-treated animals indicated only 28 genes differ-
entially abundant at all time-points, and 47genes altered at two ormore
(Fig. 2C). An evaluation of the TCDD-dependent changes revealed 18
genes differentially abundant inmale liver (Fig. 2D) and 7 genes altered
in female liver (Fig. 2D) at all four time-points. These analyses also
showed that, in females, the largest number of dysregulated transcripts
occurred at the earliest time-point, suggesting a strong primary hepatic
response, while inmales, the largest number of dysregulated transcripts
occurred at the latest time-point indicating considerable secondary
responses within the liver. A comparison between male and femaleA)
D) E)
Fig. 2.Overview of transcriptional proﬁles. A) After normalization, samples were clustered base
along the x-axis indicates the scaled normalized abundance values (see Methods for details).
TCDD-treated and control samples. B) P-value sensitivity analysiswas performed following line
ious padjusted cutoffs, regardless of direction of change. Points labeled ‘Male’ and ‘Female’ indicat
ences between male and female corn-oil treated groups. At the 144 hour time-point, there are
threshold. Venn diagrams were generated across the time-course to visualize each comparison
femalemice. For each comparison, genes were identiﬁed as differentially expressed (padj b 0.01
male and female mice across the study.TCDD-dependent responses at each time-point revealed statistically
signiﬁcantly more overlap than expected by chance alone (Fig. 2F). For
example, overlap between male and female mice at the 144 hour
time-point (n = 150) is signiﬁcantly higher than expected by chance
(n = 17; p b 0.01).
TCDD-mediated transcriptional changes
As there are clear differences in the phenotypic sensitivity between
male and female mice as early as 1 day after exposure, such as weight
loss and the emergence of discrete necrotic foci on the liver in males
(Pohjanvirta et al., 2012), we examined transcripts differentially-
abundant at multiple time-points. Importantly, transcripts signiﬁcantly
altered following exposure to TCDD in both male and female mice are
not of interest here. We focused on transcripts signiﬁcantly altered
(padj b 0.01) at 3+ time-points in either male or female mice. In total,
20 genes met this criterion, all of which were altered in male liversB)
C)
F)
d on transcriptomic proﬁles of themost variable transcripts across the study; the color key
Clear patterns can be observed, differentiating between male and female mice, as well as
armodeling; the number of genes showing differential transcriptionwas calculated at var-
e the comparisons between TCDD and corn-oil treated groups, while ‘Sex’ indicates differ-
signiﬁcantly more altered transcripts in males, relative to females, regardless of padj-value
: C) sex-dependent, TCDD-independent differences, D) TCDD-dependent inmale and E) in
and log2|FC| N 1). F) Overlap of transcripts altered by TCDD (padj b 0.01 and log2|FC| N 1) in
A)
B)
Fig. 3. Response to TCDD by candidate genes. Coefﬁcients and signiﬁcance level of A) the top 20 candidate genes, as determined by differential expression in male mice at multiple time-
points with only minimal changes in female mice, and B) the AHR-core genes. Dot size represents magnitude of change (between TCDD treated and control groups) in log2-space, while
background shading represents signiﬁcance (FDR-adjusted p-values). Covariates indicate whether the gene contains each given transcription factor binding site (AHREI-extended, ARHEI-
full or AHREII) or whether differential binding of AHR occurred between TCDD treated and control groups (as determined using ChIP-chip data Sartor et al., 2009).
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tributed to the AHR, both the occurrences of transcription factor binding
sites and presence of AHR-binding for these candidates were assessed
(Fig. 3A, covariate bars at the right). Despite the occurrence of local
AHRE motifs for most candidates (16/20), ChIP-chip analysis indicated
that only one candidate displayed direct AHR-binding. Interestingly,
there was no overlap between the presence of AHRE motifs and AHR-
binding, suggesting the involvement of additional transcription factors
or regulatory mechanisms. Finally, to verify that the observed
transcriptomic differences between sexes are in fact TCDD-dependent,
we examined those candidates identiﬁed above, including Fmo2,
Fmo3, Nr1i3 and Ces4a, within the sex-dependent/TCDD-independent
comparison (Supplementary Fig. 6A). In this comparison, coefﬁcients
represent differences between livers of male and female vehicle control
mice at each time-point, with a positive value indicating increased
abundance in the hepatic tissue of males relative to females. We do in
fact observe statistically signiﬁcant differences between sexes in certain
candidate targets, speciﬁcally Fmo2 and Fmo3. However, the abundance
of these targets is signiﬁcantly lower in males relative to females in the
vehicle control group, while being higher in the male TCDD-treated
mice, relative to females. This further implicates TCDD in the induction
of these candidates in only males, the more TCDD-sensitive sex — aresult which had been previously observed (Celius et al., 2008). Nr1i3
shows a similar pattern; however, with a more modest, though statisti-
cally signiﬁcant, induction following exposure to TCDD in males. Alter-
natively, Ces4a shows increased basal abundance in the hepatic tissue
of males relative to females. Following TCDD exposure however, it is
signiﬁcantly repressed in male liver while remaining unchanged in
females.
Response of classic ‘AHR-core’ genes
As the differential sensitivity of male and female C57BL/6 mice to
TCDD has previously been shown (Pohjanvirta et al., 2012), we exam-
ined classic AHR-responsive genes (termed “AHR-core” genes) within
our study. A set of 12 genes previously shown to respond to TCDD across
multiple tissues in mice and/or rats (Ahrr, Aldh3a1, Cyp1a1, Cyp1a2,
Cyp1b1, Cyp2s1, Fmo1, Inmt, Nfe2l2, Nqo1, Tiparp, Ugt1a6) (Nebert
et al., 1993; Korkalainen et al., 2004; Boutros et al., 2008; Yeager et al.,
2009; Deb and Bandiera, 2010; Moffat et al., 2010; Watson et al.,
2014) were examined (Fig. 3B). In general, these genes are similarly al-
tered in bothmale and female hepatic tissue following TCDD-treatment
across the experiment. Therewas little difference in the sex-dependent/
TCDD-independent levels of these genes (Supplementary Fig. 6B).
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In order to better understand the functional roles of those genes
altered by TCDD exposure in the liver, identiﬁcation of enriched
pathways was performed using GoMiner software (Zeeberg et al.,
2005). In females, one pathway, toxin metabolic process, was signiﬁ-
cantly enriched in hepatic tissue at all time-points following exposure
to TCDD (Supplementary Fig. 7A). Interestingly, enrichment and signif-
icance of this process increased from6 to 24 h before steadily decreasing
towards the end of the study. In male liver, four pathways were altered
at all time-points following treatment, (Supplementary Fig. 7B). Of
these, enrichment of altered genes within the hydrogen peroxide bio-
synthetic process pathway may indicate a mechanism by which TCDD
toxicity occurs. Pathways which were found to be signiﬁcantly altered
at 3 or more time-points in either sex are shown in Supplementary
Fig. 7C.
Candidate gene validation by Western blot
To assess the functional consequences of differential transcriptomic
dysregulation, we examined protein abundance of our candidates by
Western blot. Of the top 20 candidates, antibodies for 12were available.
However following initial testing, only 5 were sufﬁciently speciﬁc, with
minimal non-speciﬁc binding and/or detection of protein at the expect-
ed size (Fig. 4, Supplementary Fig. 8). Two additional targets were
assessed: CYP1A1 was deemed a suitable positive control to identify
treated and control samples and CES1 was chosen as numerous
carboxylesterase species have been identiﬁed as being altered by
TCDD, both in the current and previous studies (Matsubara et al.,
2012). CYP1A1, CES1 and FMO3 all showed the similar responses at
the mRNA and protein levels. ATOH8, which increased in mRNA abun-
dance following TCDD exposure in the livers of both sexes, actually
decreased in protein abundance. Nr1i3mRNA was signiﬁcantly altered
in males at all time-points; however, differences in protein abundance
were not deemed statistically signiﬁcant.
Discussion
As sensitivity to TCDD-induced toxicities is highly variable among
animal models, characterization of transcriptomic alterations occurringFig. 4.Western blot validation of candidate targets. Six candidates as well as CYP1A1 and
CES1 were carried forward for further evaluation of protein abundance, as measured by
western blot. Dot size represents magnitude of change by TCDD treated relative to control
animals while background shading refers to signiﬁcance level (FDR-adjusted p-values).
Fields marked with an X indicate protein abundance could not be measured.in either sensitive or resistant animals would improve our understand-
ing of how these toxicities arise. The identiﬁcation of speciﬁc genes, and
proteins, altered in target tissues following TCDD exposure would
potentially allow for the development of treatment options for the
toxic effects of TCDD and other dioxins. To this end, we have sought to
identify TCDD-mediated transcriptional changes in C57BL/6 mice in
which males are the more sensitive sex to TCDD-induced toxicities.
Additionally, as changes in the transcriptional activity of these genes
may not be themselves causative of toxicities, we have examined the
protein abundance of candidate genes.
Time-course analyses were performed to assess the transcriptional
effects of TCDD in hepatic tissue ofmale and female C57BL/6mice. Anal-
ysis of the expression of AHR-core genes conﬁrmed treatment; however
it also highlighted differences in Cyp1a1 expression between the sexes
occurring basally (Supplementary Fig. 6). Interestingly, we observed
increased (though of modest magnitude) expression of this gene in
females relative to males, at two time-points (signiﬁcantly at 24 h) de-
spite previous suggestions that Cyp1a1 is repressed by ERα (Marques
et al., 2013). The differences observed across the time-course may be
explained as circadian effects as Cyp1a1 has been shown to exhibit
differences in expression that vary across a circadian cycle in both
sexes (Lu et al., 2013); however, as samples for the various sexes were
not time-matched (i.e., collected at different times of day), more work
is required to conﬁrm this. Additionally, a similar evaluation of the
candidate genes revealed signiﬁcant sex-dependent differences hepatic
abundance of Fmo3, Fmo2, Nr1i3 and Ces4a. Of these, differences in the
ﬂavin containing monooxygenase species have been previously identi-
ﬁed as being unrelated to diurnal variation (Celius et al., 2008).
Additionally, Fmo3has been shown to be negatively regulated by testos-
terone, with nearly absent levels in normal male liver. Upon castration,
hepatic levels of Fmo3 rise to mimic those detected in normal female
liver, independent of the availability of estrogen (Falls et al., 1997).
Similarly, Nr1i3, also known as CAR (constitutive androstane receptor)
is known to be normally inhibited by some androstane derivatives
(Forman et al., 1998) and has been shown to follow circadian rhythm
in rats (Kanno et al., 2004). To date, Ces4a has been poorly studied
and further studies are required to reveal the underlying cause of
these sex-dependent differences.
With regard to TCDD-dependent transcriptional regulation in the
liver, we identiﬁed clear differences in the transcriptomic response
between the sexes, the most obvious of which is the time-point at
which each sex shows the maximal number of altered genes
(Figs. 2D–E). Transcript abundance was greatly affected immediately
following treatment in female liver while the greatest response in
male liver was observed at the latest time-point, possibly implicating
a primary, defensive response in females and signiﬁcant secondary re-
sponses in males that may be causative of TCDD toxicity. While the
sex hormones are known to play a key role in mediating this toxicity
in mice (Pohjanvirta et al., 2012), additional factors must be at play in
order to explain the contrary sensitivities between sexes across species.
Numerous genes were observed to be signiﬁcantly altered at multi-
ple time-points in a TCDD-dependent manner in the liver of male mice,
with onlyminimal changes in females. Fmo2 and Fmo3 have been previ-
ously shown to be signiﬁcantly induced by TCDD as early as 2 h after
exposure in only male C57BL/6 mice (Celius et al., 2008). Previous
studies of Ahr-null mice have shown that this induction is a direct result
of TCDD-activation of the AHR (Tijet et al., 2006). Two species of
carboxylesterases, Ces1b and Ces4a, showed statistically signiﬁcant
variation along the time-course; however, with differing directions of
change: Ces1b showed signiﬁcantly increased hepatic expression
while Ces4a decreased in expression in TCDD-treated males relative to
control animals (Fig. 3). There has been little or no documentation to
date on the contribution of either Ces1b or Ces4a on toxic outcomes.
However a related species, Ces1d (CES3), has been previously shown
to decrease in expression following treatment with TCDD. This reduc-
tion has been attributed to secondary signaling events, and was
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lar interest is Nr1i3, which encodes CAR, a nuclear receptor that aids in
transcriptional regulation of genes associated with xenobiotic metabo-
lism (including Cyp1a1 and Cyp1a2), cell cycle, apoptosis and lipid
metabolism (Tojima et al., 2012). Activated CAR has been shown to
mediate the induction of c-Myc (Blanco-Bose et al., 2008), with chronic
activation leading to hepatocarcinoma and liver injury (Huang et al.,
2005; Yamazaki et al., 2011). Interestingly, CAR has been also been
shown to induce expression of another of our candidate genes,
Gadd45b (Yamamoto et al., 2010; Tojima et al., 2012) and this induction
has been previously implicated in liver growth (Tian et al., 2011) and
hepatic tumor promotion (Yamamoto et al., 2010). Furthermore,
GADD45β has been shown to be an inducible coactivator of CAR (Tian
et al., 2011). Finally, CAR has also been suggested to play a role in tran-
scriptional regulation of carboxylesterases (Staudinger et al., 2010).
Complicating the role of CAR in TCDD-induced hepatotoxicity is the
lack of signiﬁcant induction of Cyp2b10 as it is known to be induced
following activation of CAR (Honkakoski et al., 1998). However, as
CAR is also known to regulate genes involved in lipid metabolism and
energy homeostasis, particularly during times of metabolic stress
(Maglich et al., 2004, 2009), these results may be confounded by the
use of corn oil as a vehicle control. Further studies are required to better
understand this relationship.
Here we have shown a signiﬁcant divergence in the hepatic
transcriptional proﬁles of TCDD-treated male and female mice that
may correspond to the phenotypic difference of TCDD-toxicity. The nu-
clear receptor Nr1i3, in connection with Gadd45b and carboxylesterase
species, may have a role in the development of toxic effects in the
more TCDD-sensitive males. Further studies in additional species,
particularly in male and female rats in which the sensitivity proﬁles
are reversed, could shed light on their complex relationships and roles
in TCDD-mediated toxicity. Speciﬁcally, studies examining the tran-
scriptional role of Nr1i3, through binding site analysis and/or ChIP-
chip targeting of CAR, as well as CAR-knockouts could be especially
beneﬁcial.
Methods
Animal handling. Male and femalewild-type C57BL/6Jmicewere obtain-
ed from the National Public Health Institute, Division of Environmental
Health, Kuopio, Finland. The current substrain (C57BL/6Kuo) was gener-
ated through multiple years of inbreeding. While male mice reach
maturity at 34–38 days, female mice do not reach maturity until 6–
8 weeks of age. Therefore, to maintain similarity between groups, mice
were 12–15 weeks old at the time of this experiment. Animals were
housed in Macrolon cages with pelleted Altromin 1314 feed (Altromin
Spezialfutter GmbH & Co. KG, Lage, Germany) and tap water available
ab libitum. The housing environment was maintained at 21 °C with
50 ± 10% relative humidity and artiﬁcial illumination on a 12/12 hour
light/dark cycle. Animals were housed individually to avoid aggressive
behavior. No attempt was made to verify the stage of the estrus cycle
in female mice at termination. All study plans were approved by the
Finnish National Animal Experiment Board (Eläinkoelautakunta, ELLA;
permit code: ESLH-2008-07223/Ym-23).
Experimental design. A total of 65 animals (34 female and 31male)were
employed in this study. Animals were divided into experimental and
control groups and treated by oral gavage with a single bolus of either
TCDD dissolved in corn oil vehicle or corn oil alone (10 mL/kg). Mice
in the experimental group received a 500 μg/kg dose of TCDD. This
dose was selected as it discriminates the sexes with respect to fatality:
the approximate LD50 for male C57BL/6mice is 305 μg/kgwhile females
can tolerate over 5000 μg/kg TCDD (Pohjanvirta et al., 2012). Animals
were euthanized at 6, 24, 72 or 144 h post-treatment with carbon
dioxide, followed immediately by cardiac exsanguination. Livers were
excised and frozen in liquid nitrogen. Tissue was shipped on dry ice tothe analytical laboratory and stored at −80 °C or colder. Liver was
selected as the tissue of interest as it exhibits numerous TCDD-
induced toxicities and is the site of xenobiotic metabolism. All animal
handling and reporting comply with ARRIVE guidelines (Kilkenny
et al., 2010). Each experimental group (sex, treatment, time-point)
contained between 3 and 5 animals (Supplementary Table 1). The over-
all experimental design is outlined in Fig. 1.Microarray hybridization. RNA was isolated as described previously
(Prokopec et al., 2013). Brieﬂy, tissue samples were ground to a
ﬁne powder in liquid nitrogen using a mortar and pestle, followed
by addition of lysis buffer and rapid homogenization using a
Brinkmann Polytron (Polytron PT1600E with a PT-DA 1607
generator). RNA was isolated using an RNeasy Mini Kit (Qiagen,
Mississauga, Canada) following the manufacturer's instructions and
quantiﬁcation was performed using a NanoDrop UV spectrophotom-
eter (Thermo Scientiﬁc, Mississauga, ON). RNA integrity was veriﬁed
using RNA 6000 Nano kits on an Agilent 2100 Bioanalyzer (Agilent
Technologies, Mississauga, Canada); all samples had an RNA integri-
ty number above 8.5 and were used for downstream analyses. RNA
was assayed on Affymetrix MouseGene1.1ST arrays by The Centre
for Applied Genomics (TCAG) at The Hospital for Sick Children
(Toronto, Canada).Microarray pre-processing. Raw array data (CEL ﬁles) were loaded into
the R statistical environment (v3.0.1) using the affy package (v1.38.1)
of the BioConductor library (Gentleman et al., 2004). Gene annotation
was performed using mogene11stmmentrezgcdf (v17.1.0), a custom
EntrezGene ID map (Dai et al., 2005). Data for all samples were pre-
processed and normalized together using the RMA algorithm (Irizarry
et al., 2003). Data were assessed for distributional homogeneity and
visualized using the lattice (v0.20-23) and latticeExtra (v0.6-26)
packages (Supplementary Fig. 1); variability was observed and further
analyses performed to identify outliers. Expression levels of various
sex speciﬁc genes (Conforto and Waxman, 2012), as well as genes
found on chromosome Y, were used to verify sex of the animals.
DIANA hierarchical clustering using Pearson's correlation as a similarity
metric was used to classify animal sex; seven arrays documented to be
female were classiﬁed as male (Supplementary Fig. 2A). Similarly,
expression of Cyp1a1 was used to verify sample treatment; three of
the above arrays (untreated) also displayed Cyp1a1 levels equivalent
to TCDD-treated animals (Supplementary Fig. 2B). To identify the
point at which sample mix-ups may have occurred, qPCR was
performed to compare Cyp1a1 levels in cDNA prepared in house to
that prepared and returned by TCAG for all samples. In all cases, samples
prepared in house displayed the expected results, while those from
TCAG did not (data not shown). In addition, gDNA was isolated from
stored tissue for samples identiﬁed above, as well as a subsample of
the remaining samples for comparison purposes, and Sry detection
performed by PCR to validate the sample sex. Again, all samples as the
expected sex (data not shown), indicating a sample mix-up error
immediately prior to analysis. In total, seven arrays (1 treated, 6 control,
all female) were excluded from the analysis. Remaining arrays were re-
normalized as above and quality re-assessed; no outliers were detected
(Supplementary Fig. 3). Probe-level ﬁltering was performed to remove
probes with intensity levels below background intensity, identiﬁed by
evaluation of chromosome Y probes in female animals (Supplementary
Fig. 4). Probes with greatest variance (variance N 2.0) were visualized
using a heatmap; normalized intensity values were scaled (mean-cen-
tered with standard deviation-scaling) and both probes and samples
were clustered using DIANA, as described above. Sample and array
information are provided in Supplementary Table 1. Raw and pre-
processed microarray data are available in the GEO repository under
accession GSE61037.
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to identify differentially expressed genes using the limma package
(v3.16.7) for R (v3.0.1). Speciﬁcally, linear modeling was performed
separately for each time-point using a nested interaction design [Y =
Sex + Sex: TCDD] to identify genes with differential expression, such
that Sex evaluates genes in a sex-dependent/TCDD-independent
manner and Sex:TCDD identiﬁes differentially expressed genes in a
sex- and TCDD-dependent manner. Standard errors of the coefﬁcients
were adjusted using an empirical Bayes moderation of the standard
error (Smyth, 2004) and model-based t-tests were applied to the
coefﬁcients, followed by false-discovery rate adjustment for multiple
testing (Storey and Tibshirani, 2003). A full list of annotated genes
with coefﬁcients representing magnitude of differential expression
and FDR-corrected p-values (padj-values) is provided in Supplementary
Table 2. For downstream analyses, a threshold of padj b 0.01 and
absolute log2-foldchange N 1 was used to deﬁne statistically signiﬁcant
genes. Venn diagrams were generated using the VennDiagram package
(v1.6.7) to visualize overlap between groups (Chen and Boutros, 2011),
and hypergeometric testing used to determine signiﬁcance of overlap
(data not shown). Coefﬁcients and signiﬁcance of candidate genes
were visualized using lattice (v0.20-29) and latticeExtra (v0.6-26)
packages for R.
Analysis of AHR-binding. In order to determine whether TCDD alters
binding of the AHR to candidate genes, we performed an analysis of
AHR-DNA interactions using publicly available chromatin immunopre-
cipitation DNA microarray (ChIP-chip) data. Raw CEL ﬁles for TCDD-
treated (GSM299310, GSM299311) and control (DMSO-treated;
GSM299306, GSM299307) mouse liver cells were downloaded from
the GEO repository (Series GSE11850) (Sartor et al., 2009). Data were
RMA normalized using the oligo package (v1.28.2) in R (v3.1.0) and
probes were annotated to genomic locations using the binary probe
map (NCBI build 35) provided by Affymetrix. Probes were further
mapped to speciﬁc gene symbols (TSS ± 1000 bp) using cisGenome
(Ji et al., 2008) and refFlat tables (mm7, downloaded on June 2, 2014)
(Karolchik et al., 2003). Student's t-tests were used to identify AHR
enrichment between TCDD treated and control samples. For each
gene, the probe with the lowest p-value was reported (Supplementary
Table 3).
Transcription factor binding site analysis. To further verify the role of the
AHR in TCDD-mediated transcriptional regulation, we performed a
transcription-factor binding site analysis by searching for typical AHR-
binding motif sequences. Speciﬁcally, we examined 4 motifs: AHRE-I
(core), AHRE-I (extended), AHRE-I (full) (Denison and Whitlock,
1995), and AHRE-II (Sogawa et al., 2004), with sequences: GCGTG,
TNGCGTG, [T|G]NGCGTG[A|C][G|C]A, and CATG{N6}C[T|A]TG respec-
tively. Transcription start sites for each gene (TSS ± 3000 bp) were
identiﬁed using refLink and refFlat tables (mm9; obtained from the
UCSC genomebrowser on July 15, 2014), and sequenceswere examined
for the above motifs. Counts for each motif in each gene are provided in
Supplementary Table 4.
Pathway analysis. Pathway analysis was performed using GoMiner
software (Zeeberg et al., 2005). Speciﬁcally, the web interface tool for
High-Throughput GOMiner analysis (application build 454, database
build 2011-01) was used to associate those genes signiﬁcantly altered
by TCDD exposure (thresholds described above) in each experiment
with known gene ontologies. Genes of interest were checked against a
random sample of the dataset using a FDR threshold of 0.1 and 1000
randomizations. All mouse databases and look-up options were used,
as were all GO evidence codes and ontologies. A minimum of ﬁve
genes was required to identify enrichment. Results were visualized
using the VennDiagram (v1.6.9), lattice (v0.20-29), and latticeExtra
(v0.6-26) packages for R.Protein analysis. Western blot analyses were performed as described
previously (Prokopec et al., 2014). Brieﬂy, total protein was isolated
using Tissue Extraction Reagent I (Life Technologies, Burlington, ON)
supplemented with cOmplete protease inhibitor cocktail (Roche,
Laval, QC). Bradford reagent (Sigma-Aldrich, Oakville, Canada) was
used for quantiﬁcation, and protein was diluted with additional extrac-
tion reagent to a ﬁnal concentration of 10 μg/μL. Protein was loaded into
each well of a Novex 4–12% Bis–Tris midi-gel system (65 μg/sample)
and electrophoresed for 40 min at 200 V with MES running buffer
(Life Technologies). Protein was subsequently transferred to PVDF
membrane using the iBlot system (program P0 for 7 minutes, Life
Technologies). Blots were blocked using 5% non-fat milk or LI-COR
blocking buffer (Mandel Scientiﬁc, Guelph, ON) for 60 min at room
temperature. Primary antibodies were purchased from Abcam (Abcam
Inc., Toronto, ON). Antibodies were diluted to the speciﬁed concentra-
tions in 5% non-fat milk or LI-COR blocking buffer supplemented with
0.1% Tween-20 and blots were incubated overnight at 4 °C or for 2 h
at room temperature. Blots were washed three times with PBS
supplemented with 0.1% Tween-20 at room temperature for 5 min
each, followed by incubation with secondary antibody (LI-COR IRDye-
labeled secondary antibody) at a 1:10,000 dilution in the same buffer
as for the primary incubation with 0.01% SDS, for 4 h at 4 °C or 1 h at
room temperature. Blots were washed as above and scanned using the
Odyssey quantitative western blot near-infrared system (LI-COR
Biosciences, Lincoln, NE, USA) using default settings. Average band
intensities were ﬁrst adjusted for background levels, followed by
normalization with HPRT and ACTIN (Prokopec et al., 2014). Order-
ing information and speciﬁc incubation conditions for each antibody
(as determined through extensive optimization) are provided in
Supplementary Table 5. Unlike for the transcriptomic analyses, all
65 animals were used for proteomic validation as tissue samples val-
idated as expected.
Authors' contributions
Animal handling: RP
Sample preparation: SDP, JDW
Performed statistical and bioinformatics analyses: SDP; JL
Wrote the ﬁrst draft of the manuscript: SDP
Initiated the project: RP, PCB
Supervised research: RP, PCB
Approved the manuscript: all authors
Conﬂict of interest statement
All authors declare that they have no conﬂicts of interest.
Funding sources
This study was conducted with the support of the Academy of
Finland (Grant Nos. 123345 and 261232 to RP), the Canadian Institutes
of Health Research (Grant No.MOP-57903 to Dr. Allan B. Okey and PCB),
and the Ontario Institute for Cancer Research to PCB through funding
provided by the Government of Ontario. PCB was supported by a CIHR
New Investigator Award and a Terry Fox Research Institute New
Investigator Award. The above funders had no involvement in the
study design, in the collection, analysis and interpretation of data, in
the writing of the document or in the decision to submit the work for
publication.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.taap.2015.02.012.
Acknowledgments
The authors thank all members of the Boutros lab for helpful sugges-
tions and support, as well as Nicholas B. Buchner, Blair Gannon and
195S.D. Prokopec et al. / Toxicology and Applied Pharmacology 284 (2015) 188–196Karthika Yoganathan for help with analyte preparation, and Arja
Moilanen, Virpi Tiihonen, Janne Korkalainen, Dr. Jere Lindén, Dr.
Hanna Miettinen and Susanna Lukkarinen for excellent technical
assistance.References
Blanco-Bose,W.E., Murphy, M.J., Ehninger, A., Offner, S., Dubey, C., Huang,W.,Moore, D.D.,
Trumpp, A., 2008. C-Myc and its target FoxM1 are critical downstream effectors of
constitutive androstane receptor (CAR)mediated direct liver hyperplasia. Hepatology
48, 1302–1311.
Boutros, P.C., Yan, R., Moffat, I.D., Pohjanvirta, R., Okey, A.B., 2008. Transcriptomic re-
sponses to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in liver: comparison of rat
and mouse. BMC Genomics 9, 419.
Boverhof, D.R., Burgoon, L.D., Tashiro, C., Chittim, B., Harkema, J.R., Jump, D.B.,
Zacharewski, T.R., 2005. Temporal and dose-dependent hepatic gene expression pat-
terns in mice provide new insights into TCDD-Mediated hepatotoxicity. Toxicol. Sci.
85, 1048–1063.
Boverhof, D.R., Burgoon, L.D., Tashiro, C., Sharratt, B., Chittim, B., Harkema, J.R.,
Mendrick, D.L., Zacharewski, T.R., 2006. Comparative toxicogenomic analysis of
the hepatotoxic effects of TCDD in Sprague Dawley rats and C57BL/6 mice.
Toxicol. Sci. 94, 398–416.
Bunger, M.K., Moran, S.M., Glover, E., Thomae, T.L., Lahvis, G.P., Lin, B.C., Bradﬁeld, C.A.,
2003. Resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity and abnormal liver
development in mice carrying a mutation in the nuclear localization sequence of
the aryl hydrocarbon receptor. J. Biol. Chem. 278, 17767–17774.
Celius, T., Roblin, S., Harper, P.A., Matthews, J., Boutros, P.C., Pohjanvirta, R., Okey, A.B.,
2008. Aryl hydrocarbon receptor-dependent induction of ﬂavin-containing
monooxygenase mRNAs in mouse liver. Drug Metab. Dispos. 36, 2499–2505.
Chen, H., Boutros, P.C., 2011. VennDiagram: a package for the generation of highly-
customizable Venn and Euler diagrams in R. BMC Bioinformatics 12, 35.
Conforto, T.L., Waxman, D.J., 2012. Sex-speciﬁc mouse liver gene expression: genome-
wide analysis of developmental changes from pre-pubertal period to young adult-
hood. Biol. Sex Differ. 3, 9.
Dai, M., Wang, P., Boyd, A.D., Kostov, G., Athey, B., Jones, E.G., Bunney, W.E., Myers, R.M.,
Speed, T.P., Akil, H., Watson, S.J., Meng, F., 2005. Evolving gene/transcript deﬁnitions
signiﬁcantly alter the interpretation of GeneChip data. Nucleic Acids Res. 33, e175.
Deb, S., Bandiera, S.M., 2010. Characterization of a new cytochrome P450 enzyme,
CYP2S1, in rats: its regulation by aryl hydrocarbon receptor agonists. Toxicology
267, 91–98.
Denison, M.S., Whitlock Jr., J.P., 1995. Xenobiotic-inducible transcription of cytochrome
P450 genes. J. Biol. Chem. 270, 18175–18178.
Dere, E., Lee, A.W., Burgoon, L.D., Zacharewski, T.R., 2011. Differences in TCDD-elicited
gene expression proﬁles in human HepG2, mouse Hepa1c1c7 and rat H4IIE hepato-
ma cells. BMC Genomics 12, 193.
Diliberto, J.J., Akubue, P.I., Luebke, R.W., Birnbaum, L.S., 1995. Dose-response relationships
of tissue distribution and induction of CYP1A1 and CYP1A2 enzymatic activities
following acute exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice.
Toxicol. Appl. Pharmacol. 130, 197–208.
Enan, E., Overstreet, J.W., Matsumura, F., VandeVoort, C.A., Lasley, B.L., 1996. Gender
differences in the mechanism of dioxin toxicity in rodents and in nonhuman
primates. Reprod. Toxicol. 10, 401–411.
Falls, J.G., Ryu, D.Y., Cao, Y., Levi, P.E., Hodgson, E., 1997. Regulation of mouse liver ﬂavin-
containing monooxygenases 1 and 3 by sex steroids. Arch. Biochem. Biophys. 342,
212–223.
Fernandez-Salguero, P.M., Hilbert, D.M., Rudikoff, S., Ward, J.M., Gonzalez, F.J., 1996. Aryl-
hydrocarbon receptor-deﬁcient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-di-
oxin-induced toxicity. Toxicol. Appl. Pharmacol. 140, 173–179.
Forgacs, A.L., Dere, E., Angrish, M.M., Zacharewski, T.R., 2013. Comparative analysis of
temporal and dose-dependent TCDD-elicited gene expression in human, mouse,
and rat primary hepatocytes. Toxicol. Sci. 133, 54–66.
Forman, B.M., Tzameli, I., Choi, H.S., Chen, J., Simha, D., Seol, W., Evans, R.M., Moore, D.D.,
1998. Androstane metabolites bind to and deactivate the nuclear receptor CAR-beta.
Nature 395, 612–615.
Franc, M.A., Moffat, I.D., Boutros, P.C., Tuomisto, J.T., Tuomisto, J., Pohjanvirta, R., Okey,
A.B., 2008. Patterns of dioxin-altered mRNA expression in livers of dioxin-sensitive
versus dioxin-resistant rats. Arch. Toxicol. 82, 809–830.
Gentleman, R.C., Carey, V.J., Bates, D.M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B.,
Gautier, L., Ge, Y., Gentry, J., Hornik, K., Hothorn, T., Huber, W., Iacus, S., Irizarry, R.,
Leisch, F., Li, C., Maechler, M., Rossini, A.J., Sawitzki, G., Smith, C., Smyth, G., Tierney,
L., Yang, J.Y., Zhang, J., 2004. Bioconductor: open software development for computa-
tional biology and bioinformatics. Genome Biol. 5, R80.
Henck, J.M., New, M.A., Kociba, R.J., Rao, K.S., 1981. 2,3,7,8-tetrachlorodibenzo-p-dioxin:
acute oral toxicity in hamsters. Toxicol. Appl. Pharmacol. 59, 405–407.
Honkakoski, P., Zelko, I., Sueyoshi, T., Negishi, M., 1998. The nuclear orphan receptor CAR-
retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer
module of the CYP2B gene. Mol. Cell. Biol. 18, 5652–5658.
Huang, W., Zhang, J., Washington, M., Liu, J., Parant, J.M., Lozano, G., Moore, D.D., 2005.
Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor
constitutive androstane receptor. Mol. Endocrinol. 19, 1646–1653.
Irizarry, R.A., Hobbs, B., Collin, F., Beazer-Barclay, Y.D., Antonellis, K.J., Scherf, U., Speed,
T.P., 2003. Exploration, normalization, and summaries of high density oligonucleotide
array probe level data. Biostatistics 4, 249–264.Ji, H., Jiang, H., Ma, W., Johnson, D.S., Myers, R.M., Wong, W.H., 2008. An integrated soft-
ware system for analyzing ChIP-chip and ChIP-seq data. Nat. Biotechnol. 26,
1293–1300.
Kanno, Y., Otsuka, S., Hiromasa, T., Nakahama, T., Inouye, Y., 2004. Diurnal difference in
CAR mRNA expression. Nucl. Recept. 2, 6.
Karolchik, D., Baertsch, R., Diekhans, M., Furey, T.S., Hinrichs, A., Lu, Y.T., Roskin, K.M.,
Schwartz, M., Sugnet, C.W., Thomas, D.J., Weber, R.J., Haussler, D., Kent, W.J., 2003.
The UCSC genome browser database. Nucleic Acids Res. 31, 51–54.
Kilkenny, C., Browne, W.J., Cuthill, I.C., Emerson, M., Altman, D.G., 2010. Improving biosci-
ence research reporting: the ARRIVE guidelines for reporting animal research. PLoS
Biol. 8, e1000412.
Korkalainen, M., Tuomisto, J., Pohjanvirta, R., 2004. Primary structure and inducibility by
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) of aryl hydrocarbon receptor repressor
in a TCDD-sensitive and a TCDD-resistant rat strain. Biochem. Biophys. Res. Commun.
315, 123–131.
Kransler, K.M., McGarrigle, B.P., Swartz, D.D., Olson, J.R., 2009. Lung development in the
Holtzman rat is adversely affected by gestational exposure to 2,3,7,8-tetra-
chlorodibenzo-p-dioxin. Toxicol. Sci. 107, 498–511.
Lu, Y.F., Jin, T., Xu, Y., Zhang, D., Wu, Q., Zhang, Y.K., Liu, J., 2013. Sex differences in the
circadian variation of cytochrome p450 genes and corresponding nuclear receptors
in mouse liver. Chronobiol. Int. 30, 1135–1143.
Maglich, J.M., Watson, J., McMillen, P.J., Goodwin, B., Willson, T.M., Moore, J.T., 2004. The
nuclear receptor CAR is a regulator of thyroid hormone metabolism during caloric
restriction. J. Biol. Chem. 279, 19832–19838.
Maglich, J.M., Lobe, D.C., Moore, J.T., 2009. The nuclear receptor CAR (NR1I3) regulates
serum triglyceride levels under conditions of metabolic stress. J. Lipid Res. 50,
439–445.
Magre, S., Rebourcet, D., Ishaq, M., Wargnier, R., Debard, C., Meugnier, E., Vidal, H., Cohen-
Tannoudji, J., Le Magueresse-Battistoni, B., 2012. Gender differences in transcriptional
signature of developing rat testes and ovaries following embryonic exposure to
2,3,7,8-TCDD. PLoS ONE 7, e40306.
Marques, M., Laﬂamme, L., Gaudreau, L., 2013. Estrogen receptor alpha can selectively
repress dioxin receptor-mediated gene expression by targeting DNA methylation.
Nucleic Acids Res. 41, 8094–8106.
Matsubara, T., Tanaka, N., Krausz, K.W., Manna, S.K., Kang, D.W., Anderson, E.R., Luecke, H.,
Patterson, A.D., Shah, Y.M., Gonzalez, F.J., 2012. Metabolomics identiﬁes an inﬂamma-
tory cascade involved in dioxin- and diet-induced steatohepatitis. Cell Metab. 16,
634–644.
Mimura, J., Yamashita, K., Nakamura, K., Morita, M., Takagi, T.N., Nakao, K., Ema, M.,
Sogawa, K., Yasuda, M., Katsuki, M., Fujii-Kuriyama, Y., 1997. Loss of teratogenic
response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah
(dioxin) receptor. Genes Cells 2, 645–654.
Moffat, I.D., Boutros, P.C., Chen, H., Okey, A.B., Pohjanvirta, R., 2010. Aryl hydrocarbon
receptor (AHR)-regulated transcriptomic changes in rats sensitive or resistant to
major dioxin toxicities. BMC Genomics 11, 263.
Nault, R., Kim, S., Zacharewski, T.R., 2013. Comparison of TCDD-elicited genome-wide
hepatic gene expression in Sprague–Dawley rats and C57BL/6 mice. Toxicol. Appl.
Pharmacol. 267, 184–191.
Nebert, D.W., Puga, A., Vasiliou, V., 1993. Role of the Ah receptor and the dioxin-inducible
[Ah] gene battery in toxicity, cancer, and signal transduction. Ann. N. Y. Acad. Sci. 685,
624–640.
Nukaya, M., Walisser, J.A., Moran, S.M., Kennedy, G.D., Bradﬁeld, C.A., 2010. Aryl hy-
drocarbon receptor nuclear translocator in hepatocytes is required for aryl hy-
drocarbon receptor-mediated adaptive and toxic responses in liver. Toxicol.
Sci. 118, 554–563.
Pohjanvirta, R., 2009. Transgenic mouse lines expressing rat AH receptor variants—a new
animal model for research on AH receptor function and dioxin toxicity mechanisms.
Toxicol. Appl. Pharmacol. 236, 166–182.
Pohjanvirta, R., Tuomisto, J., 1994. Short-term toxicity of 2,3,7,8-tetrachlorodibenzo-p-di-
oxin in laboratory animals: effects, mechanisms, and animal models. Pharmacol. Rev.
46, 483–549.
Pohjanvirta, R., Vartiainen, T., Uusi-Rauva, A., Monkkonen, J., Tuomisto, J., 1990. Tissue
distribution, metabolism, and excretion of 14C-TCDD in a TCDD-susceptible and a
TCDD-resistant rat strain. Pharmacol. Toxicol. 66, 93–100.
Pohjanvirta, R., Unkila, M., Tuomisto, J., 1993. Comparative acute lethality of 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD), 1,2,3,7,8-pentachlorodibenzo-p-dioxin and
1,2,3,4,7,8-hexachlorodibenzo-p-dioxin in the most TCDD-susceptible and the most
TCDD-resistant rat strain. Pharmacol. Toxicol. 73, 52–56.
Pohjanvirta, R., Wong, J.M., Li, W., Harper, P.A., Tuomisto, J., Okey, A.B., 1998. Point muta-
tion in intron sequence causes altered carboxyl-terminal structure in the aryl hydro-
carbon receptor of the most 2,3,7,8-tetrachlorodibenzo-p-dioxin-resistant rat strain.
Mol. Pharmacol. 54, 86–93.
Pohjanvirta, R., Viluksela, M., Tuomisto, J.T., Unkila, M., Karasinska, J., Franc, M.A.,
Holowenko, M., Giannone, J.V., Harper, P.A., Tuomisto, J., Okey, A.B., 1999. Physico-
chemical differences in the AH receptors of the most TCDD-susceptible and the
most TCDD-resistant rat strains. Toxicol. Appl. Pharmacol. 155, 82–95.
Pohjanvirta, R., Miettinen, H., Sankari, S., Hegde, N., Linden, J., 2012. Unexpected gender
difference in sensitivity to the acute toxicity of dioxin in mice. Toxicol. Appl.
Pharmacol. 262, 167–176.
Prokopec, S.D., Buchner, N.B., Fox, N.S., Chong, L.C., Mak, D.Y., Watson, J.D., Petronis, A.,
Pohjanvirta, R., Boutros, P.C., 2013. Validating reference genes within a mouse
model system of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) toxicity. Chem. Biol.
Interact. 205, 63–71.
Prokopec, S.D., Watson, J.D., Pohjanvirta, R., Boutros, P.C., 2014. Identiﬁcation of reference
proteins for western blot analyses in mouse model systems of 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD) toxicity. PLoS ONE 9 (10), e110730.
196 S.D. Prokopec et al. / Toxicology and Applied Pharmacology 284 (2015) 188–196Sartor, M.A., Schnekenburger, M., Marlowe, J.L., Reichard, J.F., Wang, Y., Fan, Y., Ma, C.,
Karyala, S., Halbleib, D., Liu, X., Medvedovic, M., Puga, A., 2009. Genomewide analysis
of aryl hydrocarbon receptor binding targets reveals an extensive array of gene
clusters that control morphogenetic and developmental programs. Environ. Health
Perspect. 117, 1139–1146.
Schecter, A., Birnbaum, L., Ryan, J.J., Constable, J.D., 2006. Dioxins: an overview. Environ.
Res. 101, 419–428.
Schwetz, B.A., Norris, J.M., Sparschu, G.L., Rowe, U.K., Gehring, P.J., Emerson, J.L., Gerbig,
C.G., 1973. Toxicology of chlorinated dibenzo-p-dioxins. Environ. Health Perspect. 5,
87–99.
Shen, C., Chen, Y., Huang, S., Wang, Z., Yu, C., Qiao, M., Xu, Y., Setty, K., Zhang, J., Zhu, Y., Lin,
Q., 2009. Dioxin-like compounds in agricultural soils near e-waste recycling sites
from Taizhou area, China: chemical and bioanalytical characterization. Environ. Int.
35, 50–55.
Silkworth, J.B., Carlson, E.A., McCulloch, C., Illouz, K., Goodwin, S., Sutter, T.R., 2008.
Toxicogenomic analysis of gender, chemical, and dose effects in livers of TCDD- or
aroclor 1254-exposed rats using a multifactor linear model. Toxicol. Sci. 102,
291–309.
Smyth, G.K., 2004. Linear models and empirical bayes methods for assessing differential
expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3 (Article3).
Sogawa, K., Numayama-Tsuruta, K., Takahashi, T., Matsushita, N., Miura, C., Nikawa, J.,
Gotoh, O., Kikuchi, Y., Fujii-Kuriyama, Y., 2004. A novel induction mechanism of the
rat CYP1A2 gene mediated by Ah receptor-Arnt heterodimer. Biochem. Biophys.
Res. Commun. 318, 746–755.
Staudinger, J.L., Xu, C., Cui, Y.J., Klaassen, C.D., 2010. Nuclear receptor-mediated regulation
of carboxylesterase expression and activity. Expert Opin. Drug Metab. Toxicol. 6,
261–271.
Storey, J.D., Tibshirani, R., 2003. Statistical signiﬁcance for genomewide studies. Proc. Natl.
Acad. Sci. U. S. A. 100, 9440–9445.
Theobald, H.M., Peterson, R.E., 1997. In utero and lactational exposure to 2,3,7,8-
tetrachlorodibenzo-p-dioxin: effects on development of the male and female repro-
ductive system of the mouse. Toxicol. Appl. Pharmacol. 145, 124–135.Tian, J., Huang, H., Hoffman, B., Liebermann, D.A., Ledda-Columbano, G.M., Columbano, A.,
Locker, J., 2011. Gadd45beta is an inducible coactivator of transcription that facilitates
rapid liver growth in mice. J. Clin. Invest. 121, 4491–4502.
Tijet, N., Boutros, P.C., Moffat, I.D., Okey, A.B., Tuomisto, J., Pohjanvirta, R., 2006. Aryl
hydrocarbon receptor regulates distinct dioxin-dependent and dioxin-independent
gene batteries. Mol. Pharmacol. 69, 140–153.
Tojima, H., Kakizaki, S., Yamazaki, Y., Takizawa, D., Horiguchi, N., Sato, K., Mori, M., 2012.
Ligand dependent hepatic gene expression proﬁles of nuclear receptors CAR and PXR.
Toxicol. Lett. 212, 288–297.
Watson, J.D., Prokopec, S.D., Smith, A.B., Okey, A.B., Pohjanvirta, R., Boutros, P.C., 2014.
TCDD dysregulation of 13 AHR-target genes in rat liver. Toxicol. Appl. Pharmacol.
274 (3), 445–454.
Yamamoto, Y., Moore, R., Flavell, R.A., Lu, B., Negishi, M., 2010. Nuclear receptor CAR re-
presses TNFalpha-induced cell death by interacting with the anti-apoptotic
GADD45B. PLoS ONE 5, e10121.
Yamazaki, Y., Moore, R., Negishi, M., 2011. Nuclear receptor CAR (NR1I3) is essential for
DDC-induced liver injury and oval cell proliferation in mouse liver. Lab. Investig. 91,
1624–1633.
Yao, C.Q., Prokopec, S.D., Watson, J.D., Pang, R., P'ng, C., Chong, L.C., Harding, N.J.,
Pohjanvirta, R., Okey, A.B., Boutros, P.C., 2012. Inter-strain heterogeneity in rat hepatic
transcriptomic responses to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol.
Appl. Pharmacol. 260, 135–145.
Yeager, R.L., Reisman, S.A., Aleksunes, L.M., Klaassen, C.D., 2009. Introducing the “TCDD-
inducible AhR-Nrf2 gene battery”. Toxicol. Sci. 111, 238–246.
Zeeberg, B.R., Qin, H., Narasimhan, S., Sunshine, M., Cao, H., Kane, D.W., Reimers, M.,
Stephens, R.M., Bryant, D., Burt, S.K., Elnekave, E., Hari, D.M., Wynn, T.A.,
Cunningham-Rundles, C., Stewart, D.M., Nelson, D., Weinstein, J.N., 2005. High-
Throughput GoMiner, an ‘industrial-strength’ integrative gene ontology tool for
interpretation of multiple-microarray experiments, with application to studies of
Common Variable Immune Deﬁciency (CVID). BMC Bioinformatics 6, 168.
